These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37699967)

  • 1. Left ventricular hypertrophy and metabolic resetting in the Notch3-deficient adult mouse heart.
    Del Gaudio F; Liu D; Andaloussi Mäe M; Braune EB; Hansson EM; Wang QD; Betsholtz C; Lendahl U
    Sci Rep; 2023 Sep; 13(1):15022. PubMed ID: 37699967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered hemodynamics and vascular reactivity in a mouse model with severe pericyte deficiency.
    Stobart JL; Erlebach E; Glück C; Huang SF; Barrett MJ; Li M; Vinogradov SA; Klohs J; Zarb Y; Keller A; Weber B
    J Cereb Blood Flow Metab; 2023 May; 43(5):763-777. PubMed ID: 36545806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A state of reversible compensated ventricular dysfunction precedes pathological remodelling in response to cardiomyocyte-specific activity of angiotensin II type-1 receptor in mice.
    Frentzou GA; Drinkhill MJ; Turner NA; Ball SG; Ainscough JF
    Dis Model Mech; 2015 Aug; 8(8):783-94. PubMed ID: 26092119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch3 is necessary for blood vessel integrity in the central nervous system.
    Henshall TL; Keller A; He L; Johansson BR; Wallgard E; Raschperger E; Mäe MA; Jin S; Betsholtz C; Lendahl U
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):409-20. PubMed ID: 25477343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic impairment in response to early induction of C/EBPβ leads to compromised cardiac function during pathological hypertrophy.
    Banerjee D; Datta Chaudhuri R; Niyogi S; Roy Chowdhuri S; Poddar Sarkar M; Chatterjee R; Chakrabarti P; Sarkar S
    J Mol Cell Cardiol; 2020 Feb; 139():148-163. PubMed ID: 31958467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch signaling regulates platelet-derived growth factor receptor-beta expression in vascular smooth muscle cells.
    Jin S; Hansson EM; Tikka S; Lanner F; Sahlgren C; Farnebo F; Baumann M; Kalimo H; Lendahl U
    Circ Res; 2008 Jun; 102(12):1483-91. PubMed ID: 18483410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.
    Xu M; Xue RQ; Lu Y; Yong SY; Wu Q; Cui YL; Zuo XT; Yu XJ; Zhao M; Zang WJ
    Cardiovasc Res; 2019 Mar; 115(3):530-545. PubMed ID: 30165480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction.
    Xu X; Fassett J; Hu X; Zhu G; Lu Z; Li Y; Schnermann J; Bache RJ; Chen Y
    Hypertension; 2008 Jun; 51(6):1557-64. PubMed ID: 18391093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voluntary activity reverses spermidine-induced myocardial fibrosis and lipid accumulation in the obese male mouse.
    Mühlfeld C; Pfeiffer C; Schneider V; Bornemann M; Schipke J
    Histochem Cell Biol; 2021 Jan; 155(1):75-88. PubMed ID: 33108533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyocyte Ogt limits ventricular dysfunction in mice following pressure overload without affecting hypertrophy.
    Dassanayaka S; Brainard RE; Watson LJ; Long BW; Brittian KR; DeMartino AM; Aird AL; Gumpert AM; Audam TN; Kilfoil PJ; Muthusamy S; Hamid T; Prabhu SD; Jones SP
    Basic Res Cardiol; 2017 May; 112(3):23. PubMed ID: 28299467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure.
    Sung MM; Byrne NJ; Kim TT; Levasseur J; Masson G; Boisvenue JJ; Febbraio M; Dyck JR
    Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H552-H560. PubMed ID: 28062415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation of fatty acid oxidation by medium chain fatty acid prevents myocyte hypertrophy in H9c2 cell line.
    Ismael S; Nair RR
    Mol Cell Biochem; 2021 Jan; 476(1):483-491. PubMed ID: 33000353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cinnamic acid mitigates left ventricular hypertrophy and heart failure in part through modulating FTO-dependent N
    Cui Y; Wang P; Li M; Wang Y; Tang X; Cui J; Chen Y; Zhang T
    Biomed Pharmacother; 2023 Sep; 165():115168. PubMed ID: 37453198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLUT1 deficiency in cardiomyocytes does not accelerate the transition from compensated hypertrophy to heart failure.
    Pereira RO; Wende AR; Olsen C; Soto J; Rawlings T; Zhu Y; Riehle C; Abel ED
    J Mol Cell Cardiol; 2014 Jul; 72():95-103. PubMed ID: 24583251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Endothelial Notch Signaling Impairs Fatty Acid Transport and Leads to Metabolic and Vascular Remodeling of the Adult Heart.
    Jabs M; Rose AJ; Lehmann LH; Taylor J; Moll I; Sijmonsma TP; Herberich SE; Sauer SW; Poschet G; Federico G; Mogler C; Weis EM; Augustin HG; Yan M; Gretz N; Schmid RM; Adams RH; Gröne HJ; Hell R; Okun JG; Backs J; Nawroth PP; Herzig S; Fischer A
    Circulation; 2018 Jun; 137(24):2592-2608. PubMed ID: 29353241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy.
    Karpanen T; Bry M; Ollila HM; Seppänen-Laakso T; Liimatta E; Leskinen H; Kivelä R; Helkamaa T; Merentie M; Jeltsch M; Paavonen K; Andersson LC; Mervaala E; Hassinen IE; Ylä-Herttuala S; Oresic M; Alitalo K
    Circ Res; 2008 Oct; 103(9):1018-26. PubMed ID: 18757827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of epidermal growth factor receptor in vascular smooth muscle cells and cardiomyocytes causes arterial hypotension and cardiac hypertrophy.
    Schreier B; Rabe S; Schneider B; Bretschneider M; Rupp S; Ruhs S; Neumann J; Rueckschloss U; Sibilia M; Gotthardt M; Grossmann C; Gekle M
    Hypertension; 2013 Feb; 61(2):333-40. PubMed ID: 23248150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Remodeling Promotes Cardiac Hypertrophy by Directing Glucose to Aspartate Biosynthesis.
    Ritterhoff J; Young S; Villet O; Shao D; Neto FC; Bettcher LF; Hsu YA; Kolwicz SC; Raftery D; Tian R
    Circ Res; 2020 Jan; 126(2):182-196. PubMed ID: 31709908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.